Search PubMed⌕ Search

Biomedical subjects

A W Holmes

Publications and source records attributed to A W Holmes.

At least 19 recordsLinked to original sources

Ultrasonic assessment of skin and surgical wounds utilizing backscatter acoustic techniques to estimate attenuation.

Backscatter acoustic techniques at high ultrasonic frequencies (10-40 MHz) were utilized to investigate the ultrasonic attenuation coefficient of normal skin and the relationship between attenuation and the healing of surgical wounds ranging in age from 9 to 49 days. The attenuation coefficient was calculated with measurements from depths of 0.5 and 1.0 mm, primarily in the reticular dermis. The values for control skin ranged from 6.0 Np cm-1 at 10 mHz to 19.6 Np cm-1 at 40 MHz and a corresponding slope of 0.45 Np cm-1 MHz-1. Wound attenuation initially increased with wound age from approximately 15% of control at day 9 to 30% of control at day 34 but did not continue to increase through day 49. During the same period, however, total collagen (as a percentage of wet weight) increased at a constant rate from approximately 45% of control at day 9 to 70% of control at day 49. Thus the attenuation coefficient in healing wounds over the time period studied may be sensitive to more than total collagen content in the tissue. It may be affected by other competing factors as wounds mature such as intermolecular cross-linking, collagen fiber bundle size, and structural arrangement of fiber bundles or other tissue constituents such as proteoglycans and elastin. The observations that wound integrated attenuation using backscatter techniques over the range of 10-40 MHz substantially increased in early wounds, did not increase beyond day 34, and remained significantly lower than control values over the entire healing period studied are in agreement with the results of an independent study of the same tissue using transmission techniques at 100 MHz.

Animals↗

Nicotinic acid-induced fulminant hepatic failure.

A 46-year-old man began taking nicotinic acid, 3 g daily, for hypercholesterolemia. A month later, he developed clinical and biochemical evidence of modest hepatocellular injury, and therapy was stopped. It was restarted 6 weeks later, and 10 weeks after that, the patient presented with fulminant hepatic failure, which resolved rapidly after cessation of nicotinic acid therapy. We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.

Chemical and Drug Induced Liver Injury↗

Hepatitis among plasma fractionation workers. An industry-wide study.

An industry-wide survey of plasm fractionation facilities in the United States was conducted during 1973-74. Hepatitis was reported among the workers with varying degrees of plasma contact at all plant sites. For each of fourteen facilities in this investigation, field inspections disclosed: (1) numerous overt instances of employee-product contact: (2) inconsistent methodologic approaches at virtually all stages of the plasma fractionation process; (3) at low level of management and employee awareness regarding the potential bio-hazard identified; and (4) disparate examples of hepatitis surveillance and prophylaxis. Our data suggests that there is a high risk of hepatitis among plasma fractionation workers and, as such, much more attention needs to be focused on the reduction of health hazards within this industry.

Biological Products↗

Reye's syndrome in an adult.

Reye's syndrome (fatty infiltration of the liver with encephalopathy) is an uncommon disease of children and has not previously been noted in adult patients. We present a 25-year-old male who survived this syndrome after presenting a stuporous state. Etiologic and pathophysiologic mechanisms are considered.

Adult↗

Prevalance of antibody to hepatitis B surface antigen in various populations.

Sera from individuals with different degrees of exposure to the agent of hepatitis B were tested for antibodies to hepatitis B surface antigen (anti-HB-s) by passive hemagglutination and for hepatitis B surface antigen (HB-s Ag) by radioimmunoassay and immunoelectroosmophoresis. In a plasma fractionation plant, anti-HB-s was detected in 82 percent of workers processing human plasma and 3.3 percent were healthy carriers of the antigen. Fifty-six percent of the workers having only casual contact with plasma processing exhibited anti-HB-s and 24 percent of workers with no contact had anti-HB-s, yet HB-s Ag was not found in either of these two groups of workers. A similar correlation was shown in hospital personnel; 31 percent of employees with direct contact to serum specimens and only 8 percent without direct contact had anti-HB-s. The frequency of HB-s Ag (0.8 percent in patients with disorders not involving the liver; 49.8 percent in patients tentatively diagnosed as viral hepatitis) and anti-HB-s (14.5 percent to 28.5 percent, respectively) in selected groups of hospitalized patients varied greatly. In 508 paid blood donors, anti-HB-s was present in 19.9 percent, whereas it was present in only 6.6 percent of 1,146 volunteer donors. These data demonstrate a correlation between frequency of exposure to human blood or blood products and the prevalence of anti-HB-s.

Antibodies↗

The mythology of various hepatitis A virus isolates.

Several types of viral hepatitis may exist. Hepatitis A (MS-1 type) can be transmitted to marmosets and chimpanzees. Virus-like particles, which may be parvo- or enteroviruses and which have been demonstrated in feces of this type of hepatitis, do not share cross-reacting antigens with hepatitis B but do cross-react with fecal hepatitis A antigen. Hepatitis A (GB type), which also does not cross-react with hepatitis B, is not antigenically identical with MS-1; it can be transmitted to marmosets and it may be similar to non-type A/non-type B post-transfusion hepatitis. Hepatitits B does not cross-react either with HA particles, the faecal hepatitis type A antigen or with the MS-1 or GB strains; it can be transmitted to chimpanzees and rhesus monkeys but not to marmosets.

Animals↗